FdaApplication
BLA 761371
Identifiers
- fda_app_no: BLA761371
Properties
| Property | Value |
|---|---|
| applicant_name | Genentech, Inc. |
| application_type | BLA |
| approval_date | 2024-09-13 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OCREVUS ZUNOVO | OCRELIZUMAB AND HYALURONIDASE-OCSQ | 40MG | Injection |
1 product